Last week, positive topline results from a clinical trial with gene therapy in Huntington disease were presented in a press release from uniQure. The news hit the headlines and spread fast through the HD community. Read Professor Petersén’s comments on these results in plain language for the wider audience in The Conversation and in a statement as deputy chair for the European HD Network.

Link to the The Conversation’s website (opens in a new window)

Link to the EHDN website (opens in a new window)